Conexeu Sciences Inc.

1 known investors

Conexeu Sciences develops regenerative medicine and tissue-engineering technologies for aesthetics, wound care, and surgical applications. The company holds proprietary intellectual property in collagen and extracellular matrix (ECM) biology and is advancing translational programs toward clinical use.